4/3
08:00 am
npce
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
Medium
Report
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
4/2
04:05 pm
npce
NeuroPace Announces Refocusing of Product Portfolio
Medium
Report
NeuroPace Announces Refocusing of Product Portfolio
3/26
08:00 am
npce
NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
Low
Report
NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
3/5
11:36 am
npce
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at Cantor Fitzgerald from $19.00 to $20.00. They now have an "overweight" rating on the stock.
Medium
Report
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at Cantor Fitzgerald from $19.00 to $20.00. They now have an "overweight" rating on the stock.
3/4
06:13 pm
npce
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Medium
Report
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
3/4
04:05 pm
npce
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results
Low
Report
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results
3/3
09:15 pm
npce
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
Medium
Report
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
3/3
04:15 pm
npce
NeuroPace to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
Low
Report
NeuroPace to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
3/4/2025
04:05 pm
npce
neuropace, inc.
BEAT
Report
-6.6%
neuropace, inc.
3/4/2025
04:05 pm
npce
neuropace, inc.
BEAT
Report
-6.6%
neuropace, inc.
3/4/2025
04:05 pm
npce
neuropace, inc.
BEAT
Report
-6.6%
neuropace, inc.
3/4/2025
04:05 pm
npce
neuropace, inc.
BEAT
Report
-6.6%
neuropace, inc.
4/2
04:39 pm
npce
Form 8-K NeuroPace Inc For: Mar 27
Medium
Report
Form 8-K NeuroPace Inc For: Mar 27
3/24
06:11 pm
npce
Form 4 NeuroPace Inc For: Mar 24 Filed by: Morrell Martha
Low
Report
Form 4 NeuroPace Inc For: Mar 24 Filed by: Morrell Martha
3/20
05:18 pm
npce
Form 4 NeuroPace Inc For: Mar 10 Filed by: Kuhn Rebecca
Medium
Report
Form 4 NeuroPace Inc For: Mar 10 Filed by: Kuhn Rebecca
3/20
05:16 pm
npce
Form 4 NeuroPace Inc For: Feb 27 Filed by: Becker Joel
Medium
Report
Form 4 NeuroPace Inc For: Feb 27 Filed by: Becker Joel
3/5
04:09 pm
npce
Form 4 NeuroPace Inc For: Mar 03 Filed by: Morrell Martha
Medium
Report
Form 4 NeuroPace Inc For: Mar 03 Filed by: Morrell Martha
3/5
04:08 pm
npce
Form 4 NeuroPace Inc For: Mar 03 Filed by: Kuhn Rebecca
Medium
Report
Form 4 NeuroPace Inc For: Mar 03 Filed by: Kuhn Rebecca
3/4
05:29 pm
npce
Form S-8 NeuroPace Inc
Medium
Report
Form S-8 NeuroPace Inc
3/4
05:07 pm
npce
Form 10-K NeuroPace Inc For: Dec 31
Medium
Report
Form 10-K NeuroPace Inc For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register